CVS Caremark, Express Scripts, OptumRx: How PBM Drug Appeals Differ

If you've ever spent 45 minutes on hold with a PBM only to learn you submitted your appeal to the wrong department, you already know the frustration that prompted this article. The three major pharmacy benefit managers — CVS Caremark, Express Scripts, and OptumRx — collectively manage prescription drug benefits for roughly 75-80% of commercially insured Americans. And while they all follow federal appeal requirements under ERISA and ACA regulations, the way you navigate their appeal processes couldn't be more different. Knowing those differences isn't just helpful — it's the difference between a successful override and a denied claim that costs your patient hundreds of dollars out of pocket.

---

Why PBM Appeals Aren't One-Size-Fits-All

Here's something that trips up even experienced billing managers: federal law sets the floor for appeal rights, not the ceiling. PBMs layer their own processes, timelines, and documentation requirements on top of the basics. What works beautifully for an Express Scripts formulary exception appeal might get kicked back immediately at OptumRx if you use the wrong form or route it through the wrong portal.

The stakes are real. A recent analysis of specialty drug denials found that well-documented appeals succeed at rates 40-60% higher than minimally documented ones. That gap isn't about the clinical merits of the case — it's often about procedural compliance. Knowing which PBM you're dealing with before you start drafting your appeal letter is step one.

---

CVS Caremark: Navigating the Formulary Exception Maze

Caremark is, frankly, one of the more process-heavy PBMs out there. Their formulary is large, but so is their documentation checklist. A few things worth knowing:

Their preferred channel is the Caremark Provider Portal, and routing appeals by fax still works but creates delays. If you're not using the portal, you're adding 3-5 business days to your timeline unnecessarily.

For formulary exceptions — requesting a non-covered or non-preferred drug — Caremark generally requires:

• A completed prior authorization (PA) request first (even for appeals)


• Clinical notes supporting medical necessity dated within the last 12 months


• Documentation of formulary alternative failures, including specific dosing and duration


• For specialty drugs, they often require a specialty pharmacy attestation

One thing that catches people off guard: Caremark distinguishes between a formulary exception and a coverage determination appeal, and they're routed differently. If you submit a formulary exception request through their standard PA channel, and the denial was actually a coverage determination (e.g., a step therapy issue), you may need to resubmit through their member services escalation pathway. Always read the denial notice carefully — the specific language tells you which pathway applies.

Pro tip: Caremark's expedited appeal timeline (72 hours for urgent cases) is legitimately faster than their standard 30-day window. If there's any clinical urgency, document it explicitly in your submission. "Patient is experiencing uncontrolled symptoms affecting daily functioning" is stronger than a generic urgent flag.

---

Express Scripts: Documentation-Heavy, But Predictable

Express Scripts (now technically part of Evernorth/Cigna, though it operates largely independently for employer clients) has a reputation for being demanding on documentation — but here's the thing: they're consistent. Once you learn their system, it's actually fairly predictable.

Their appeals fall into a cleaner three-tier structure: internal appeal first, then an Independent Review Organization (IRO) review, then external appeal. What distinguishes their process:

• They want peer-reviewed clinical evidence. Not just clinical notes. If you're appealing a denial for a specialty biologic, citing treatment guidelines from ACR, AHRQ, or relevant specialty societies makes a measurable difference.


• Formulary exceptions require exhaustive step therapy documentation. Express Scripts is particularly rigorous here — they want to see not just that alternatives were tried, but that they were tried at adequate doses for adequate durations.


• Their fax-based PA system is still widely used for physician offices, but appeals for employer-sponsored plans often route through a different fax number or portal than retail pharmacy appeals. Getting this wrong means your appeal ends up in the wrong queue.

A real-world scenario: a rheumatology practice manager I spoke with last year described submitting three appeals for the same patient on a JAK inhibitor. The first two failed not because of clinical grounds, but because she was routing a plan-level appeal through the retail pharmacy channel. Once she identified the correct employer plan appeal address from the denial letter, the third attempt — same clinical documentation — was approved within 10 days.

---

OptumRx: The UnitedHealth Connection and What It Means for Appeals

OptumRx operates within the broader UnitedHealth Group ecosystem, which affects your appeals process in ways that aren't immediately obvious. If your patient's pharmacy benefits run through OptumRx but their medical benefits are through UnitedHealthcare, certain appeals — especially for specialty drugs with both medical and pharmacy benefit implications — may need to be coordinated across both systems.

Key distinctions with OptumRx:

• Their clinical criteria are often aligned with UHC's coverage policies, which are publicly available on the UnitedHealthcare provider portal. Reviewing these before you appeal gives you a roadmap for exactly what language and evidence they're looking for.


• Appeals involving specialty drugs may require coordination with Optum Specialty Pharmacy directly — not just the PBM appeals department.


• OptumRx has a Peer-to-Peer review option that's underutilized. Requesting a peer-to-peer call between the treating physician and OptumRx's medical reviewer can resolve complex cases faster than written appeals alone, especially for oncology and rare disease cases.

The 2025-2026 period has seen OptumRx tighten criteria around GLP-1 medications significantly. If you're appealing denials for semaglutide or tirzepatide for weight management (not diabetes), expect to need detailed documentation of BMI history, comorbidities, previous weight loss interventions, and documented failure of lifestyle interventions — and even then, coverage varies considerably by plan.

---

Practical Tips That Actually Move the Needle

Regardless of which PBM you're dealing with, a few practices consistently improve appeal outcomes:

• Always start with the denial letter. The specific denial reason code and language determines your appeal pathway, timeline, and documentation requirements. Skipping this step is where most errors begin.


• Match your clinical language to their criteria. Generic letters don't work. Mirror the PBM's stated coverage criteria in your documentation.


• Track your appeals in writing. Keep confirmation numbers, submission dates, and contact names. Escalation works much better when you have a paper trail.


• Don't sleep on the IRO option. Independent Review Organizations uphold patient appeals at surprisingly high rates — often 30-40% — for denials that seemed like dead ends.


• Use available tools. AI-powered appeal generators have improved significantly and can help you draft well-structured, criteria-specific letters faster — though human clinical review before submission is still essential.

---

The Bottom Line

PBM appeals aren't a mystery, but they do require knowing the specific rules of the game you're playing. CVS Caremark wants procedural precision and the right portal. Express Scripts wants clinical depth and peer-reviewed evidence. OptumRx benefits from understanding the broader UHC infrastructure and using peer-to-peer options when available.

Your next step: pull the last five denied claims from each PBM you work with regularly and audit them against the criteria in this article. Chances are you'll spot patterns — maybe it's a routing issue, maybe it's documentation gaps — that you can fix systematically. Appeals are winnable. You just have to play by the right PBM's rules.

---

Tags: pharmacy, PBM, Caremark, Express Scripts, OptumRx, appeals